20.470
20.47 (0%)
As of Dec 24, 2024
Genmab A/S [GMAB]
Source:
Company Overview
Genmab A/S is an international biotechnology company with a core purpose that our team will improve the lives of patients through innovative and differentiated antibody therapeutics.
Country | Denmark |
Headquarters | 1253 copenhagen k |
Phone Number | |
Industry | manufacturing |
CEO | Jan G. J. Van De Winkel |
Website | genmab.com |